Journal of the American College of Nutrition, Vol 16, Issue 5 404-410, Copyright © 1997 by American College of Nutrition

CLINICAL TRIAL

Nutritional factors influencing the glucose/insulin system: chromium

R. A. Anderson
Nutrient Requirements and Functions Laboratory, United States Department of Agriculture, Beltsville, Maryland 20705-2350, USA.

Chromium (Cr) improves the glucose/insulin system in subjects with hypoglycemia, hyperglycemia, diabetes and hyperlipemia with no detectable effects on control subjects. Chromium improves insulin binding, insulin receptor number, insulin internalization, beta cell sensitivity and insulin receptor enzymes with overall increases in insulin sensitivity. There have been several studies involving Cr supplementation of subjects with NIDDM and/or lipemia and most have reported beneficial effects of Cr on the glucose/insulin system. In a recent study, Chinese subjects with NIDDM were divided into three groups of 60 subjects and supplemented with placebo, 100 or 500 micrograms of Cr as chromium picolinate 2 times per day for 4 months. Improvements in the glucose/insulin system were highly significant in the subjects receiving 500 micrograms twice per day with less or no significant improvements in the subjects receiving 100 micrograms twice per day after 2 and 4 months. In summary, Cr is involved in the control of the glucose/insulin system and the amount, and likely form of chromium, are critical when evaluating the role of chromium in this system.

This article has been cited by other articles:

				Z. Q. Wang, X. H. Zhang, J. C. Russell, M. Hulver, and W. T. Cefalu Chromium Picolinate Enhances Skeletal Muscle Cellular Insulin Signaling In Vivo in Obese, Insulin-Resistant JCR:LA-cp Rats J. Nutr., February 1, 2006; 136(2): 415 - 420. [Abstract] [Full Text] [PDF]

				W. T. Cefalu and F. B. Hu Role of Chromium in Human Health and in Diabetes Diabetes Care, November 1, 2004; 27(11): 2741 - 2751. [Full Text] [PDF]

				G. J Ryan, N. S Wanko, A. R Redman, and C. B Cook Chromium as Adjunctive Treatment for Type 2 Diabetes Ann. Pharmacother., June 1, 2003; 37(6): 876 - 885. [Abstract] [Full Text] [PDF]

				W. T. Cefalu, Z. Q. Wang, X. H. Zhang, L. C. Baldor, and J. C. Russell Oral Chromium Picolinate Improves Carbohydrate and Lipid Metabolism and Enhances Skeletal Muscle Glut-4 Translocation in Obese, Hyperinsulinemic (JCR-LA Corpulent) Rats J. Nutr., June 1, 2002; 132(6): 1107 - 1114. [Abstract] [Full Text] [PDF]

				S. L. Volpe, H.-W. Huang, K. Larpadisorn, and I. I. Lesser Effect of Chromium Supplementation and Exercise on Body Composition, Resting Metabolic Rate and Selected Biochemical Parameters in Moderately Obese Women Following an Exercise Program J. Am. Coll. Nutr., August 1, 2001; 20(4): 293 - 306. [Abstract] [Full Text] [PDF]

				F. Fernandez, A. G. Miquel, R. Martinez, E. Serra, J. Guinea, F. J. Narbaiza, A. Caseras, and I. V. Baanante Dietary Chromic Oxide Does Not Affect the Utilization of Organic Compounds but Can Alter the Utilization of Mineral Salts in Gilthead Sea Bream Sparus aurata J. Nutr., May 1, 1999; 129(5): 1053 - 1059. [Abstract] [Full Text]

				H. G. Preuss The Insulin System: Influence of Antioxidants J. Am. Coll. Nutr., April 1, 1998; 17(2): 101 - 102. [Full Text] [PDF]